- LEVILevi's$9.1BReported
LEVIQ1 2025
Levi's
View full reportEPS
Estimated
$0.29
Actual
$0.3519.8%
Revenue
Estimated
$1.7B
Actual
$1.5B10.9%
- PHVSPharvaris$2.1BReported
PHVSQ4 2024
Pharvaris
View full reportEPS
Estimated
-$0.73
Actual
-$0.6412.3%
Revenue
Estimated
$0.00
Actual
—
- GBXGreenbrier$1.5BReported
GBXQ2 2025
Greenbrier
View full reportEPS
Estimated
$1.77
Actual
$1.5611.9%
Revenue
Estimated
$859.5M
Actual
$762.1M11.3%
- ZVRAZevra$674MReported
ZVRAQ4 2024
Zevra
View full reportEPS
Estimated
-$0.40
Actual
-$0.6767.5%
Revenue
Estimated
$8.9M
Actual
$12.0M34.4%
- PLAYDave & Buster's$469MReported
PLAYQ4 2024
Dave & Buster's
View full reportEPS
Estimated
$0.72
Actual
$0.2466.9%
Revenue
Estimated
$537.8M
Actual
$534.5M0.6%
- SSSSSuRo Capital$359MReported
SSSSQ4 2024
SuRo Capital
View full reportEPS
Estimated
-$0.21
Actual
-$0.0195.2%
Revenue
Estimated
$492.0K
Actual
$4.7M849.9%
- CXAICXApp$12.0MReported
CXAIQ4 2024
CXApp
View full reportEPS
Estimated
$0.00
Actual
$0.00
Revenue
Estimated
$2.0M
Actual
$0.00100.0%
- RPMRPM$13.6BReported
RPMQ3 2025
RPM
View full reportEPS
Estimated
$0.96
Actual
$0.4058.3%
Revenue
Estimated
$1.7B
Actual
$1.5B11.6%
- WBAWalgreens$10.4BReported
WBAQ2 2025
Walgreens
View full reportEPS
Estimated
$0.55
Actual
-$3.30696.2%
Revenue
Estimated
$38.7B
Actual
$38.6B0.2%
- WDFCWD-40$2.7BReported
WDFCQ2 2025
WD-40
View full reportEPS
Estimated
$1.40
Actual
$2.1956.0%
Revenue
Estimated
$152.0M
Actual
$146.1M3.9%
- TLRYTilray$676MReported
TLRYQ3 2025
Tilray
View full reportEPS
Estimated
-$0.03
Actual
-$0.852772.3%
Revenue
Estimated
$209.4M
Actual
$185.8M11.3%
- CRMDCorMedix$661MReported
CRMDQ4 2024
CorMedix
View full reportEPS
Estimated
$0.05
Actual
$0.22337.1%
Revenue
Estimated
$20.2M
Actual
$31.2M54.6%
- CALMCal-Maine Foods$3.6BReported
CALMQ3 2025
Cal-Maine Foods
View full reportEPS
Estimated
$1.55
Actual
$10.38570.7%
Revenue
Estimated
$578.3M
Actual
$1.4B145.1%
- AEHRAehr$3.1BReported
AEHRQ3 2025
Aehr
View full reportEPS
Estimated
$0.04
Actual
-$0.02148.8%
Revenue
Estimated
$17.6M
Actual
$18.3M4.1%
- KRUSKura Sushi$696MReported
KRUSQ2 2025
Kura Sushi
View full reportEPS
Estimated
-$0.10
Actual
-$0.1443.6%
Revenue
Estimated
$64.9M
Actual
$64.9M0.0%
- MAMAMamas Creations$590MReported
MAMAQ4 2025
Mamas Creations
View full reportEPS
Estimated
$0.03
Actual
$0.0430.1%
Revenue
Estimated
$31.6M
Actual
$33.6M6.2%
- GOROGold Resource$219MReported
GOROQ4 2024
Gold Resource
View full reportEPS
Estimated
-$0.05
Actual
$0.00100.0%
Revenue
Estimated
$16.7M
Actual
$0.00100.0%
- INGING$76.2BReported
INGQ4 2024
ING
View full reportEPS
Estimated
$0.41
Actual
$0.403.7%
Revenue
Estimated
$5.8B
Actual
$5.8B0.0%
- DALDelta$54.2BReported
DALQ1 2025
Delta
View full reportEPS
Estimated
$0.66
Actual
$0.3743.6%
Revenue
Estimated
$13.1B
Actual
$14.0B7.0%
- NEOGNeogen$2.0BReported
NEOGQ3 2025
Neogen
View full reportEPS
Estimated
$0.14
Actual
-$0.05136.5%
Revenue
Estimated
$233.8M
Actual
$221.0M5.5%
- SMPLSimply Good Foods$1.1BReported
SMPLQ2 2025
Simply Good Foods
View full reportEPS
Estimated
$0.40
Actual
$0.369.9%
Revenue
Estimated
$360.6M
Actual
$359.7M0.3%
- STZConstellation Brands$24.5BReported
STZQ4 2025
Constellation Brands
View full reportEPS
Estimated
$2.32
Actual
-$2.09190.2%
Revenue
Estimated
$2.1B
Actual
$2.2B1.2%
- PSMTPricesmart$5.3BReported
PSMTQ2 2025
Pricesmart
View full reportEPS
Estimated
$1.44
Actual
$1.450.5%
Revenue
Estimated
$1.4B
Actual
$1.4B0.2%
- RELLRichardson Electronics$244MReported
RELLQ3 2025
Richardson Electronics
View full reportEPS
Estimated
$0.10
Actual
$0.1112.5%
Revenue
Estimated
$55.8M
Actual
$53.8M3.5%
- GMABGenmab$101BReported
GMABQ4 2024
Genmab
View full reportEPS
Estimated
$0.29
Actual
$0.85196.2%
Revenue
Estimated
$895.3M
Actual
$921.6M2.9%
- KMXCarMax$6.2BReported
KMXQ4 2025
CarMax
View full reportEPS
Estimated
$0.62
Actual
-$0.85236.5%
Revenue
Estimated
$6.0B
Actual
$6.0B0.2%
- CVACCureVac$1.0BReported
CVACQ4 2024
CureVac
View full reportEPS
Estimated
-$0.09
Actual
-$0.20116.8%
Revenue
Estimated
$2.0M
Actual
$15.1M646.2%
- LOVELovesac$238MReported
LOVEQ4 2025
Lovesac
View full reportEPS
Estimated
$1.92
Actual
$2.1310.7%
Revenue
Estimated
$232.3M
Actual
$241.5M3.9%
- JPMJPMorgan$795BReported
JPMQ1 2025
JPMorgan
View full reportEPS
Estimated
$4.37
Actual
$5.0716.0%
Revenue
Estimated
$43.6B
Actual
$45.3B4.0%
- MSMorgan Stanley$321BReported
MSQ1 2025
Morgan Stanley
View full reportEPS
Estimated
$2.20
Actual
$2.6018.2%
Revenue
Estimated
$16.2B
Actual
$17.7B9.2%
- WFCWells Fargo$235BReported
WFCQ1 2025
Wells Fargo
View full reportEPS
Estimated
$1.20
Actual
$1.3915.9%
Revenue
Estimated
$20.3B
Actual
$20.1B0.8%
- BLKBlackRock$170BReported
BLKQ1 2025
BlackRock
View full reportEPS
Estimated
$10.69
Actual
$9.649.8%
Revenue
Estimated
$5.4B
Actual
$5.3B1.8%
- BKBNY Mellon$96.5BReported
BKQ1 2025
BNY Mellon
View full reportEPS
Estimated
$1.41
Actual
$1.5812.4%
Revenue
Estimated
$4.6B
Actual
$4.8B3.2%
- FASTFastenal$51.4BReported
FASTQ1 2025
Fastenal
View full reportEPS
Estimated
$0.52
Actual
$0.520.4%
Revenue
Estimated
$2.0B
Actual
$2.0B1.5%
- MOVMovado$786MReported
MOVQ4 2025
Movado
View full reportEPS
Estimated
$0.38
Actual
$0.81113.0%
Revenue
Estimated
$178.0M
Actual
$653.4M267.1%
- INVLearn Cw Investment$493MReported
INVQ4 2024
Learn Cw Investment
View full reportEPS
Estimated
—
Actual
-$1.42
Revenue
Estimated
—
Actual
$456.0K
- CMCLCaledonia Mining$458MReported
CMCLQ4 2024
Caledonia Mining
View full reportEPS
Estimated
—
Actual
$0.44
Revenue
Estimated
—
Actual
$47.5M
- KALAKala Bio$42.6MReported
KALAQ4 2024
Kala Bio
View full reportEPS
Estimated
-$2.47
Actual
-$1.7429.6%
Revenue
Estimated
—
Actual
$0.00
- BOCBoston Omaha$407MReported
BOCQ4 2024
Boston Omaha
View full reportEPS
Estimated
$0.00
Actual
-$0.04
Revenue
Estimated
$27.9M
Actual
$108.3M287.9%
- OBIOOrchestra Biomed$238MReported
OBIOQ4 2024
Orchestra Biomed
View full reportEPS
Estimated
-$0.43
Actual
-$1.66286.0%
Revenue
Estimated
$829.6K
Actual
$2.6M218.0%
- PLCEChildren's Place$96.6MReported
PLCEQ4 2024
Children's Place
View full reportEPS
Estimated
$0.26
Actual
-$4.531819.2%
Revenue
Estimated
$418.5M
Actual
$1.4B231.3%
- TRAWOnconova$23.0MReported
TRAWQ4 2024
Onconova
View full reportEPS
Estimated
-$9.55
Actual
-$35.21268.7%
Revenue
Estimated
$60.0K
Actual
$56.0K6.7%
- AZNAstraZeneca$213BReported
AZNQ4 2024
AstraZeneca
View full reportEPS
Estimated
$1.07
Actual
$1.042.3%
Revenue
Estimated
$13.3B
Actual
$14.9B11.6%